TETRAPHASE PHARMACEUTICALS INC Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2020-01-28: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2020-01-24; Total offering amount $9,997,939.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2020-01-28 | Rule 506(b) | Equity; OptionToAcquire | 2020-01-24 | $9,997,939 | $9,997,939 | $0 | 1 |